-- 週四,Raymond James 將加拿大國家鐵路公司 (CNR.TO, CNI) 的目標價從 162 美元上調至 170 美元,並將加拿大太平洋堪薩斯城鐵路公司 (CP.TO, CP) 的目標股價從 120 美元上調至 125 美元。 分析師 Steve Hansen 維持對這兩家加拿大鐵路公司的「跑贏大盤」評級。 Hansen 在給客戶的報告中表示:“加拿大鐵路運輸量在 2026 年的開局好於預期。儘管 1 月份受惡劣天氣影響,但受穀物、多式聯運和石油化工行業持續利好因素的推動,2 月和 3 月的運輸量有所加速增長。” 這位分析師表示:“加拿大國家鐵路公司 (CN) 和加拿大太平洋堪薩斯城鐵路公司 (CPKC) 的業績均超出我們的預期。” 「在2026財年貨運量預期表現平平之後,加拿大國家鐵路公司(CN)表現尤為突出,不僅連續第二個季度超出市場預期,也超越了其最接近的競爭對手。股價也隨之上漲,」漢森表示。 「展望未來,我們對這兩家鐵路公司仍保持謹慎樂觀。儘管美國進一步採取貿易行動的威脅依然存在,但我們認為,在以下三個因素的支撐下,短途至中途貨運量增長的路徑是切實可行的:1)持續的散貨運輸利好因素(穀物、鉀肥);2)逐步增強的自救能力;以及3)美國經濟和貨運前景的快速改善。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.